The FDA Fast-Tracks Its Review of Psilocybin and Methylone, 2 Promising Psychedelics
It has been six days since President Donald Trump signed an executive order aimed at facilitating regulatory review of psychedelics that have shown potential as psychotherapeutic catalysts. As promised then, the Food and Drug…















